Lanton Law Returns to Moderate Most Favored Nation Panel for Pharmacy Times

healthcarelife sciences
Written By Ron Lanton

Lanton Law retuned to moderate the third and final panel on MFN for Pharmacy Times titled “How Trump Is Disrupting Pharma: Exploring the Impacts of MFN, Tariffs and DTC on Drug Markets.” The panel discussion can be heard here.

Ron Lanton
Previous

New Trans-Atlantic Drug Pricing Deal: What Supply Chain Stakeholders Must Know
Next

Lanton Law Quoted in Bloomberg Law